|
1
|
Liu L, Zhao C, Heng HH and Ganz T: The
human beta-defensin-1 and alpha-defensins are encoded by adjacent
genes: Two peptide families with differing disulfide topology share
a common ancestry. Genomics. 43:316–320. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jia HP, Schutte BC, Schudy A, Linzmeier R,
Guthmiller JM, Johnson GK, Tack BF, Mitros JP, Rosenthal A, Ganz T
and McCray PB Jr: Discovery of new human beta-defensins using a
genomics-based approach. Gene. 263:211–218. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ganz T: Defensins: Antimicrobial peptides
of innate immunity. Nat Rev Immunol. 3:710–720. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou YS, Webb S, Lettice L, Tardif S,
Kilanowski F, Tyrrell C, MacPherson H, Semple F, Tennant P, Baker
T, et al: Partial deletion of chromosome 8 β-defensin cluster
confers sperm dysfunction and infertility in male mice. PLoS Genet.
9:e10038262013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilson SS, Wiens ME and Smith JG:
Antiviral mechanisms of human defensins. J Mol Biol. 425:4965–4980.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dhople V, Krukemeyer A and Ramamoorthy A:
The human beta-defensin-3, an antibacterial peptide with multiple
biological functions. Biochim Biophys Acta. 1758:1499–1512. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wehkamp J, Wang G, Kübler I, Nuding S,
Gregorieff A, Schnabel A, Kays RJ, Fellermann K, Burk O, Schwab M,
et al: The Paneth cell alpha-defensin deficiency of ileal Crohn's
disease is linked to Wnt/Tcf-4. J Immunol. 179:3109–3118. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang D, Chertov O, Bykovskaia SN, Chen Q,
Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM and
Oppenheim JJ: Beta-defensins: Linking innate and adaptive immunity
through dendritic and T cell CCR6. Science. 286:525–528. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Rayahi IA and Sanyi RH: The overlapping
roles of antimicrobial peptides and complement in recruitment and
activation of tumor-associated inflammatory cells. Front Immunol.
6:22015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Masters JS and Harris DJ Jr: Low
recurrence rate of pterygium after excision with conjunctival
limbal Autograft: A retrospective study with long-term follow-up.
Cornea. 34:1569–1572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lucas RM, McMichael AJ, Armstrong BK and
Smith WT: Estimating the global disease burden due to ultraviolet
radiation exposure. Int J Epidemiol. 37:654–667. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nubile M, Curcio C, Lanzini M, Calienno R,
Iezzi M, Mastropasqua A, Di Nicola M and Mastropasqua L: Expression
of CREB in primary pterygium and correlation with cyclin D1, ki-67,
MMP7, p53, p63, Survivin and Vimentin. Ophthalmic Res. 50:99–107.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Detorakis ET and Spandidos DA:
Pathogenetic mechanisms and treatment options for ophthalmic
pterygium: Trends and perspectives (Review). Int J Mol Med.
23:439–447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu L, Wu J, Geng J, Yuan Z and Huang D:
Geographical prevalence and risk factors for pterygium: A
systematic review and meta-analysis. BMJ Open. 3:e0037872013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Julio G, Lluch S, Pujol P and Merindano D:
Ocular discomfort in pterygium patients. Optom Vis Sci. 90:269–274.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rachmiel R, Leiba H and Levartovsky S:
Results of treatment with topical mitomycin C 0.02% following
excision of primary pterygium. Br J Ophthalmol. 79:233–236. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bozkir N, Yilmaz S and Maden A: Minimally
invasive pterygium surgery: A new approach for prevention of
recurrence. Eur J Ophthalmol. 18:27–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ozkurt YB, Kocams O, Comez AT, Uslu B and
Dogan OK: Treatment of primary pterygium. Optom Vis Sci.
86:1178–1181. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Varssano D, Shalev H, Lazar M and Fischer
N: Pterygium excision with conjunctival autograft: True survival
rate statistics. Cornea. 32:1243–1250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nelson JD: Impression cytology. Cornea.
7:71–81. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Singh R, Joseph A, Umapathy T, Tint NL and
Dua HS: Impression cytology of the ocular surface. Br J Ophthalmol.
89:1655–1659. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vora P, Youdim A, Thomas LS, Fukata M,
Tesfay SY, Lukasek K, Michelsen KS, Wada A, Hirayama T, Arditi M
and Abreu MT: Beta-defensin-2 expression is regulated by TLR
signaling in intestinal epithelial cells. J Immunol. 173:5398–5405.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Alp S, Skrygan M, Schlottmann R, Kreuter
A, Otte JM, Schmidt WE, Brockmeyer NH and Bastian A: Expression of
beta-defensin 1 and 2 in nasal epithelial cells and alveolar
macrophages from HIV-infected patients. Eur J Med Res. 10:1–6.
2005.PubMed/NCBI
|
|
25
|
Musumeci G, Carnazza ML, Leonardi R and
Loreto C: Expression of β-defensin-4 in ‘an in vivo and ex vivo
model’ of human osteoarthritic knee meniscus. Knee Surg Sports
Traumatol Arthrosc. 20:216–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang XF, Cao RM, Li J, Wu J, Wu SM and
Chen TX: Identification of sociodemographic and clinical factors
associated with the levels of human β-defensin-1 and human
β-defensin-2 in the human milk of Han Chinese. Br J Nutr.
111:867–874. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suarez-Carmona M, Hubert P, Delvenne P and
Herfs M: Defensins: ‘Simple’ antimicrobial peptides or
broad-spectrum molecules? Cytokine Growth Factor Rev. 26:361–370.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ikeda A, Sakimoto T, Shoji J and Sawa M:
Expression of alpha-and beta-defensins in human ocular surface
tissue. Jpn J Ophthalmol. 49:73–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Otri AM, Mohammed I, Al-Aqaba MA, Fares U,
Peng C, Hopkinson A and Dua HS: Variable expression of human Beta
defensins 3 and 9 at the human ocular surface in infectious
keratitis. Invest Ophthalmol Vis Sci. 53:757–761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Haynes RJ, McElveen JE, Dua HS, Tighe PJ
and Liversidge J: Expression of human beta-defensins in intraocular
tissues. Invest Ophthalmol Vis Sci. 41:3026–3031. 2000.PubMed/NCBI
|
|
31
|
Huang LC, Jean D, Proske RJ, Reins RY and
McDermott AM: Ocular surface expression and in vitro activity of
antimicrobial peptides. Curr Eye Res. 32:595–609. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jarczak J, Kościuczuk EM, Lisowski P,
Strzałkowska N, Jóźwik A, Horbańczuk J, Krzyżewski J, Zwierzchowski
L and Bagnicka E: Defensins: Natural component of human innate
immunity. Human Immunol. 74:1069–1079. 2013. View Article : Google Scholar
|
|
33
|
McNAMARA NA, Van R, Tuchin OS and Fleiszig
SM: Ocular surface epithelia express mRNA for human beta
defensin-2. Exp Eye Res. 69:483–490. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McDermott AM: The role of antimicrobial
peptides at the ocular surface. Ophthalmic Res. 41:60–75. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mohammed I, Suleman H, Otri AM, Kulkarni
BB, Chen P, Hopkinson A and Dua HS: Localization and gene
expression of human beta-defensin 9 at the human ocular surface
epithelium. Invest Ophthalmol Vis Sci. 51:4677–4682. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Garreis F, Schlorf T, Worlitzsch D, Steven
P, Bräuer L, Jäger K and Paulsen FP: Roles of human beta-defensins
in innate immune defense at the ocular surface: Arming and alarming
corneal and conjunctival epithelial cells. Histochem Cell Biol.
134:59–73. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pazgier M, Hoover DM, Yang D, Lu W and
Lubkowski J: Human beta-defensins. Cell Mol Life Sci. 63:1294–1313.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matsushita I, Hasegawa K, Nakata K, Yasuda
K, Tokunaga K and Keicho N: Genetic variants of human
beta-defensin-1 and chronic obstructive pulmonary disease. Biochem
Biophys Res Commun. 291:17–22. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Levy H, Raby BA, Lake S, Tantisira KG,
Kwiatkowski D, Lazarus R, Silverman EK, Richter B, Klimecki WT,
Vercelli D, et al: Association of defensin beta-1 gene
polymorphisms with asthma. J Allergy Clin Immunol. 115:252–258.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Andresen E, Günther G, Bullwinkel J, Lange
C and Heine H: Increased expression of beta-defensin 1 (DEFB1) in
chronic obstructive pulmonary disease. PLoS One. 6:e218982011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Proud D, Sanders SP and Wiehler S: Human
rhinovirus infection induces airway epithelial cell production of
human beta-defensin 2 both in vitro and in vivo. J Immunol.
172:4637–4645. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Meloni M, De Servi B, Marasco D and Del
Prete S: Molecular mechanism of ocular surface damage: Application
to an in vitro dry eye model on human corneal epithelium. Mol Vis.
17:113–126. 2011.PubMed/NCBI
|
|
43
|
Abedin A, Mohammed I, Hopkinson A and Dua
HS: A novel antimicrobial peptide on the ocular surface shows
decreased expression in inflammation and infection. Invest
Ophthalmol Vis Sci. 49:28–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Premratanachai P, Joly S, Johnson GK,
McCray PB Jr, Jia HP and Guthmiller JM: Expression and regulation
of novel human beta-defensins in gingival keratinocytes. Oral
Microbiol Immunol. 19:111–117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
McDermott AM: Defensins and other
antimicrobial peptides at the ocular surface. Ocul Surf. 2:229–247.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Machado LR and Ottolini B: An evolutionary
history of defensins: A role for copy number variation in
maximizing host innate and adaptive immune responses. Front
Immunol. 6:1152015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bolaños-Jiménez R, Navas A,
López-Lizárraga EP, de Ribot FM, Peña A, Graue-Hernández EO and
Garfias Y: Ocular surface as barrier of innate immunity. Open
Ophthalmol J. 9:49–55. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chalkia AK, Spandidos DA and Detorakis ET:
Viral involvement in the pathogenesis and clinical features of
ophthalmic pterygium (Review). Int J Mol Med. 32:539–543. 2013.
View Article : Google Scholar : PubMed/NCBI
|
